[1]
YULIANI, S.H. 2021. NANOPARTICLE AS THE STRATEGY FOR THE DEVELOPMENT OF SARS-COV-2 ANTIVIRAL DRUGS. International Journal of Applied Pharmaceutics. 13, 5 (Sep. 2021), 33–43. DOI:https://doi.org/10.22159/ijap.2021v13i5.42604.